Palmitic Acid

Palmitic Acid

SCHEMBL516266

CCCCCCCCCCCCCCCC(=O)O.Cc1ncc(CO)c(CO)c1O

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.63
▸ HSD17B10 Q99714 2/20 0.63
▸ KDM4E B2RXH2 2/20 0.63
▸ HPGD P15428 2/20 0.63
▸ LMNA P02545 2/20 0.51
▸ HDAC1 Q13547 1/20 0.46
▸ GPR84 Q9NQS5 7/20 0.45
▸ PPARG P37231 7/20 0.45
▸ PPARD Q03181 7/20 0.45
▸ PPARA Q07869 7/20 0.45
▸ HDAC11 Q96DB2 5/20 0.45
▸ TSHR P16473 4/20 0.45
▸ PTPN1 P18031 3/20 0.45
▸ TLR2 O60603 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ FABP4 P15090 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ SLC22A6 Q4U2R8 1/20 0.45
▸ SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridoxine SCHEMBL483437 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Palmitic Acid SCHEMBL4798201 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Dodecanoate SCHEMBL29381594 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Decanoic Acid SCHEMBL30694319 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Palmitic Acid SCHEMBL29361257 1.00 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EHPGDLMNA
Palmitic Acid SCHEMBL15540470 0.99 ALDH1A1 (0.61) ALDH1A1HSD17B10KDM4EHPGDLMNA
Azelaic Acid SCHEMBL5981734 0.95 KDM4E (0.71) ALDH1A1HSD17B10KDM4EHPGDLMNA
Pyridoxine SCHEMBL28806638 0.93 KDM4E (0.73) ALDH1A1HSD17B10KDM4EHPGDLMNA
Pyridoxine SCHEMBL31514964 0.87 KDM4E (0.77) ALDH1A1HSD17B10KDM4EHPGDLMNA
Pyridoxine SCHEMBL405402 0.81 KDM4E (0.83) ALDH1A1HSD17B10KDM4EHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122055125-A Rubber seed oil modified particles and compositions thereof 联合利华知识产权控股有限公司 2026-05-15 — — CN disclosed
US-20260090969-A1 COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS Nuchido Limited (GB) 2026-04-02 — — US disclosed
EP-3578161-B1 METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC ADEKA CORP (JP) 2025-11-12 — — EP disclosed
WO-2025082770-A1 PARTICLES MODIFIED WITH RUBBER SEED OIL AND COMPOSITION THEREOF UNILEVER IP HOLDINGS B.V. (NL) 2025-04-24 — — WO disclosed
CN-119656062-A Composition for protecting cells from oxidative and mitochondrial stresses 努其杜有限公司 2025-03-21 — — CN disclosed
CN-112423726-B Composition for protecting cells from oxidative and mitochondrial stresses 努其杜有限公司 2024-12-27 — — CN disclosed
CN-115444780-B Personal care compositions with glutathione precursors comprising nicotinamide and amino acids 联合利华知识产权控股有限公司 2024-10-15 — — CN disclosed
CN-114767562-B Topical skin lightening additives and compositions with amino acids and nicotinamide compounds 联合利华知识产权控股有限公司 2024-05-10 — — CN disclosed
EP-3763353-B1 METHOD FOR IMPROVING WATER SOLUBILITY OF SPARINGLY-SOLUBLE COMPONENT ADEKA CORP (JP) 2024-01-24 — — EP disclosed
CN-111163753-B Inorganic sun-screening agent with high ultraviolet radiation protection 维佐尔有限责任公司 2023-10-31 — — CN disclosed
EP-2094233-A2 SINGLE-CRYSTAL PLATY BARIUM SULFATE IN COSMETIC COMPOSITIONS Unilever PLC (GB) 2009-09-02 — — EP disclosed
EP-2068818-A1 COSMETIC COMPOSITIONS WITH ETHYLENE BRASSYLATE Unilever PLC (GB) 2009-06-17 — — EP disclosed
EP-2004132-A1 COSMETIC COMPOSITION WITH SOFT FOCUS PROPERTIES UNILEVER PLC (GB) 2008-12-24 — — EP disclosed
WO-2008145582-A1 PERSONAL CARE COMPOSITIONS WITH ENHANCED FRAGRANCE DELIVERY UNILEVER PLC (GB) 2008-12-04 — — WO disclosed
WO-2008145598-A1 ENHANCED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS UNILEVER PLC (GB) 2008-12-04 — — WO disclosed
WO-2008077728-A2 SINGLE-CRYSTAL PLATY BARIUM SULFATE IN COSMETIC COMPOSITIONS UNILEVER PLC (GB) 2008-07-03 — — WO disclosed
WO-2008058982-A1 COSMETIC COMPOSITION UNILEVER PLC (GB) 2008-05-22 — — WO disclosed
WO-2008028900-A1 COSMETIC COMPOSITIONS WITH ETHYLENE BRASSYLATE UNILEVER PLC (GB) 2008-03-13 — — WO disclosed
WO-2007116003-A1 COSMETIC COMPOSITION WITH SOFT FOCUS PROPERTIES UNILEVER PLC (GB) 2007-10-18 — — WO disclosed
WO-2002072039-A2 TOPICAL PREPARATIONS AND FOOD PREPARATIONS COMPRISING A PYRIDOXINE-ALPHA-D-GLUCOSE PENTAPHARM LTD (CH) 2002-09-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090969-A1 COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS NLN, TFAM, CYP27B1 ALDH1A1 2717/4885HSD17B10 1746/4885KDM4E 4276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback